Clinical Research Directory
Browse clinical research sites, groups, and studies.
Testing Settings of NovaResp's cMAP® Software During Home PAP Therapy
Sponsor: NovaResp Technologies Inc
Summary
The goal of this clinical trial is to identify which settings of proactive therapy work best in OSA patients who regularly adhere to PAP therapy at home. The main question(s) it aims to answer are: * To assess how different settings of proactive therapy affect therapy effectiveness * To assess whether proactive therapy works similarly across different PAP devices Participants will undergo conventional APAP therapy and two modes of proactive therapy on two different PAP devices. Nights in which conventional APAP was used and nights in which proactive therapy was used to see which settings treated patients most effectively.
Official title: Experimental Evaluation of cMAP® Therapy Parameters Delivered Through Commercial Positive Airway Pressure (PAP) Devices in Adults Using PAP Therapy at Home
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2027-11-30
Completion Date
2028-11-30
Last Updated
2026-10-27
Healthy Volunteers
No
Conditions
Interventions
Dynamic cMAP
Uses AI to make predictions of future apneic events. A deterministic algorithm uses output predictions to determine pressure.
Direct cMAP
Uses AI to directly determine the therapy pressure to prevent future apneic events
Locations (1)
NovaResp Technologies Inc.
Halifax, Nova Scotia, Canada